CME Group financials
$263.22−0.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B | $4.88B | $4.87B | $4.31B | $3.64B | $3.60B |
| Gross profit | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B | $4.88B | $4.87B | $4.31B | $3.64B | $3.60B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B | $2.64B | $2.59B | $2.61B | $2.31B | $2.20B |
| Net income | $4.02B | $3.48B | $3.19B | $2.66B | $2.62B | $2.11B | $2.12B | $1.96B | $4.06B | $1.53B |
| Net margin | 61.7% | 56.8% | 57.1% | 52.9% | 55.8% | 43.1% | 43.5% | 45.5% | 111.5% | 42.7% |
| Diluted EPS | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 | $5.87 | $5.91 | $5.71 | $11.94 | $4.53 |
| EBITDA | $4.56B | $4.27B | $3.79B | $3.38B | $3.03B | $3.10B | $3.06B | $2.86B | $2.52B | $2.43B |
| Operating cash flow | $4.28B | $3.69B | $3.45B | $3.06B | $2.40B | $2.72B | $2.67B | $2.44B | $1.75B | $1.73B |
| Free cash flow | $4.19B | $3.60B | $3.38B | $2.97B | $2.28B | $2.52B | $2.43B | $2.32B | $1.67B | $1.64B |
| Diluted shares | 360.3M | 359.9M | 359.5M | 359.2M | 358.9M | 358.5M | 358.2M | 343.7M | 340.2M | 339.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.42B | $2.89B | $2.91B | $2.72B | $2.83B | $1.63B |
| Short-term investments | $125.0M | $113.2M | $111.7M | $96.0M | $115.0M | $100.9M |
| Total debt | $163.08B | $3.43B | $3.43B | $3.44B | $3.45B | $3.44B |
| Total assets | $198.42B | $137.45B | $129.71B | $174.18B | $196.78B | $124.66B |
| Total liabilities | $169.70B | $110.96B | $102.97B | $147.30B | $169.38B | $98.31B |
| Shareholders' equity | $28.73B | $26.49B | $26.74B | $26.88B | $27.40B | $26.35B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology